| Date | Title | Description | Source |
| 07.03.2024 | MacroGenics Provides Update on Corporate Progress and 2023 F... | - | globenewsw... |
| 08.03.2023 | MacroGenics Announces Sale of TZIELD™ Royalty Interest for u... | - | globenewsw... |
| 15.02.2022 | MacroGenics Announces Date of Fourth Quarter 2021 Financial ... | ROCKVILLE, MD, Feb. 14, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutic... | marketscre... |
| 26.10.2021 | MacroGenics Announces Date of Third Quarter 2021 Financial R... | ROCKVILLE, MD, Oct. 26, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutic... | marketscre... |
| 16.09.2021 | MacroGenics : Announces Clinical Results from Cohort A Part ... | MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuxi... | marketscre... |
| 16.09.2021 | MacroGenics : Announces Clinical Results from Cohort A Part ... | 21 of 40 patients (53%) achieved confirmed responses by independent review, exceeding prespecified f... | marketscre... |
| 16.09.2021 | MacroGenics : Announces Preliminary Clinical Results from Ph... | Metastatic castration-resistant prostate cancer (mCRPC): 21 of 39 patients (54%) achieved ≥ 50% pros... | marketscre... |
| 13.09.2021 | MacroGenics : Announces Presentations at ESMO 2021 Virtual A... | ROCKVILLE, MD, Sept. 12, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceuti... | marketscre... |
| 08.09.2021 | 'Like a kid in a candy shop': Michael Ehlers gets behind R... | Nathaniel Wang
Nathaniel Wang and Andrew Geall spent years working on self-replicating RNAs at S... | endpts.com... |
| 08.09.2021 | Moderna surfaces as the first partner for Jim Wilson's r... | Top biopharma execs from Merck, Eli Lilly, Takeda and industry lobbying group PhRMA tried their best... | endpts.com... |
| 08.09.2021 | A few months into his new role at Attralus, ex-Purdue chi... | Tachi is gone, but his legacy biotechs are continuing to make news.
This morning it’s the newly born... | endpts.com... |
| 08.09.2021 | Looking for fresh start following a Duchenne disaster, ... | The leaders of Catabasis Pharmaceuticals have decreed that the biotech’s name is no more. Cat... | endpts.com... |
| 08.09.2021 | A few months into his new role at Attralus, ex-Purdue chi... | Cancer player MacroGenics scored a big win with its full approval for anti-HER2 drug Margenza last w... | endpts.com... |
| 30.08.2021 | MacroGenics : Phase 2 Trial of Enoblituzumab Plus Retifanlim... | Phase 2 Trial of Enoblituzumab Plus Retifanlimab or Tebotelimab in First-Line Treatment of Patients
... | marketscre... |
| 22.07.2021 | MacroGenics : Announces Date of Second Quarter 2021 Financia... | ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) --
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutic... | marketscre... |
| 20.05.2021 | MACROGENICS, INC.
MacroGenics Announces Preliminary Clinica... | Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response)... | marketscre... |
| 23.03.2021 | MacroGenics : Enhanced HER2-dependent immune activation by m... | Enhanced HER2-dependent Immune Activation by Margetuximab, an Investigational Fc-engineeredanti-HER2... | marketscre... |
| 28.12.2020 | MacroGenics : CELL REPORTS MEDICINE 2020 - Development and P... | Article
Development and Preliminary Clinical Activity of PD-
1-GuidedCTLA-4 Blocking Bispecific DART
... | marketscre... |
| 16.12.2020 | MacroGenics scores first FDA approval with breast cancer... | In the sustainably hot oncology field, breast cancer has attracted some of the biggest play... | endpts.com... |
| 06.02.2019 | MacroGenics’ stock price more than doubles on successful bre... | In a conference call to discuss the results Wednesday morning, some analysts conceded that their for... | medcitynew... |
| 10.12.2018 | FDA places hold on MacroGenics’ bispecific antibody trials o... | On the Nasdaq, shares of MacroGenics, which closed Friday at $16.41, fell more than 25 percent in af... | medcitynew... |
| 17.09.2018 | Here’s a look at Maryland’s publicly-traded biotech companie... | When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government i... | technical.... |
| 27.04.2017 | MacroGenics Raises $23.6M | A clinical-stage biopharmaceuticals company raised $23.6 million by selling 1.1 million shares to an... | citybizlis... |
| 27.04.2017 | MacroGenics Raises $23.6M | A clinical-stage biopharmaceuticals company raised $23.6 million by selling 1.1 million shares to an... | archive.ci... |
| 12.09.2016 | Protocols: Tillman Gerngross's Avitide goes back to the... | Avitide CEO Kevin Isett
A year ago, Avitide CEO Kevin Isett told me that a $7.6 million round wou... | endpts.com... |
| 01.11.2013 | OrbiMed closes its largest VC fund, predicts rebound in heal... | Looking back 5 to 6 years, healthcare venture capital funds raised $7.8 billion, but last year they ... | medcitynew... |
| 12.09.2013 | Rockville biotech firm MacroGenics files for IPO | Rockville-based biotech company MacroGenics filed for a $60 million initial public offering on Sept.... | technical.... |
| 05.09.2013 | MacroGenics trumpets cancer immunotherapies in $60M IPO pitc... | MacroGenics CEO & co-founder Dr. Scott Koenig
MacroGenics has taken aim at an initial public off... | fiercebiot... |
| 19.10.2007 | Life sciences briefing: Friday, Oct. 19, 2007 | Featured companies: DirectFlow, Direvo, Indigo Biosystems, MacroGenics
Direct Flow raises $27M for h... | venturebea... |
| - | OrbiMed closes its largest VC fund, predicts rebound in heal... | OrbiMed has closed its largest venture capital healthcare fund to date as two partners predict a res... | medcitynew... |
| - | MacroGenics’ stock price more than doubles on successful bre... | Shares of MacroGenics went stratospheric Wednesday following the release of data from a pivotal Phas... | medcitynew... |
| - | FDA places hold on MacroGenics’ bispecific antibody trials o... | The Food and Drug Administration placed two clinical trials of a bispecific monoclonal antibody unde... | medcitynew... |
